Bioengineers from Brigham and Women's Hospital with collaborators at the pharmaceutical company Sanofi have identified small molecules that can be used to program stem cells to home in on sites of damage, disease and inflammation. The techniques used to find and test these small molecules may represent important tools in advancing cell-based therapy, offering a new strategy for delivering cells to the right locations in the body.
http://ift.tt/18qsko6
http://ift.tt/18qsko6
No comments:
Post a Comment